ALK and non-small cell lung carcinoma: The fusion of echinoderm microtubule-associated protein-like 4 (EML4) and ALK gene by rearrangement in non-small cell lung cancer was identified[9] and developed as a target of the ALK tyrosine kinase inhibitor, crizotinib[10,11].